# 🔥 Top Trending Stocks Today (June 18, 2026) ## Top Trending by Volume & Interest (Yahoo Finance) | Ticker | Company | Price | Change | Why It's Moving | |--------|---------|-------|--------|-----------------| | **INTC** | Intel | $121.10 | **+3.46%** | AI foundry deals surging — Google's 3M TPU order, Nvidia partnership on 18A chip, Wells Fargo ($110) & Barclays ($100) upgrades on AI data center demand | | **HOOD** | Robinhood | $105.20 | **+8.78%** | Crypto trading momentum, retail investor boom | | **NBIS** | Nebius Group | $280.91 | **+5.96%** | AI infrastructure/cloud computing demand | | **BIRD** | Allbirds | $5.48 | **+39.09%** | Sharp rally on high speculative volume | | **META** | Meta Platforms | $567.58 | **-5.44%** | Pulling back despite overall tech strength | --- ## 🚀 Biggest Gainers (Explosive Moves) | Ticker | Company | Price | Change | Catalyst | |--------|---------|-------|--------|----------| | **ICCM** | IceCure Medical | $6.40 | **+200%** | New cancer cryoablation data at ECIO 2026 — ProSense showed ~90% recurrence-free outcomes in kidney tumors + 70% US install base growth post-FDA clearance | | **SNBR** | Sleep Number | $0.39 | **+121%** | Speculative bounce on micro-cap | | **QURE** | uniQure | $48.16 | **+78%** | **FDA game-changer** — FDA accepted Phase 1/2 data for AMT-130 (Huntington's gene therapy) as basis for accelerated approval; dropped sham-surgery trial requirement; BLA filing planned Q3 2026 | | **GPUS** | Hyperscale Data | $0.40 | **+53%** | AI/data center speculation | | **CAST** | FreeCast | $5.15 | **+37%** | Streaming/media momentum | | **EOSE** | Eos Energy | $7.60 | **+11.6%** | Battery storage sector strength | | **MRNA** | Moderna | $61.80 | **+11.6%** | Positive pipeline updates | --- ## 💻 Semiconductor/AI Strength Broad-based semiconductor rally today: - **AVGO** (Broadcom): +4.3% | **ARM**: +5.7% | **AMAT** (Applied Materials): +4.4% | **VRT** (Vertiv): +6.0% **Why:** Continued AI infrastructure buildout demand, with Intel specifically benefiting from foundry turnaround and major AI chip deals. --- ## 📉 Notable Losers - **CVNA** (Carvana): **-10.3%** — Sharp pullback - **ACN** (Accenture): **-5.8%** — IT services weakness - **NOW** (ServiceNow): **-5.8%** — SaaS rotation out - **KR** (Kroger): **-3.6%** --- ## 📊 Macro Context - **Fed meeting** underway — markets watching for rate signals - **Nasdaq set to rebound** (per WSJ) - **Gasoline prices falling** — consumer tailwind - Strong bifurcation: AI/semiconductor names rallying while some SaaS and consumer discretionary names sell off --- **Bottom line:** Today is dominated by two themes — (1) **AI infrastructure spending** driving Intel, Broadcom, ARM, Applied Materials, and Vertiv higher, and (2) **biotech/fda catalysts** creating massive single-stock moves in uniQure (Huntington's therapy approval path) and IceCure Medical (cancer treatment data).